JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.
暂无分享,去创建一个
A. Tefferi | T. Lasho | A. Pardanani | R. Pruthi | C. Finke | S. Schwager | K. Hussein | C. M. Finke | Kebede Hussein